Updated Jul 16, 2026 · Last SEC filing 2026-06-12
Milestone Pharmaceuticals Inc. (MIST) has filed 8 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-12. 2 Form 8-K material event filings were reported by MIST in the last 90 days. InsiderAlpha tracks every MIST SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001408443 |
|---|
| Form 4 filings (90d) | 8 |
|---|---|
| Form 8-K filings (90d) | 2 |
| Latest Form 4 filing | 2026-06-12 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oliveto Joseph | President and CEO | S — Open-market sale | 36.5K | $2.26 | $82K | SEC | |
| Nelson Jeffrey Edward | Chief Operating Officer | M — Option exercise | 20.1K | — | — | SEC | |
| Bharucha David | Chief Medical Officer | M — Option exercise | 20.1K | — | — | SEC | |
| Bharucha David | Chief Medical Officer | S — Open-market sale | 12.2K | $1.93 | $24K | SEC | |
| Nelson Jeffrey Edward | Chief Operating Officer | S — Open-market sale | 12.2K | $1.93 | $24K | SEC | |
| Muller Lorenz | Chief Commercial Officer | M — Option exercise | 20.1K | — | — | SEC | |
| Muller Lorenz | Chief Commercial Officer | S — Open-market sale | 11.2K | $1.93 | $22K | SEC | |
| Hasija Amit | CFO & EVP of Corp. Development | M — Option exercise | 20.1K | — | — | SEC | |
| Hasija Amit | CFO & EVP of Corp. Development | S — Open-market sale | 12.2K | $1.93 | $24K | SEC | |
| Oliveto Joseph | President and CEO | M — Option exercise | 66.6K | — | — | SEC | |
| Oliveto Joseph | President and CEO | S — Open-market sale | 34.5K | $1.93 | $67K | SEC | |
| Oliveto Joseph | President and CEO | S — Open-market sale [10b5-1] | 43.0K | $2.25 | $97K | SEC | |
| Oliveto Joseph | President and CEO | S — Open-market sale [10b5-1] | 500 | $2.25 | $1K | SEC | |
| Nelson Jeffrey Edward | Chief Operating Officer | S — Open-market sale | 58.0K | $2.32 | $135K | SEC | |
| Muller Lorenz | Chief Commercial Officer | S — Open-market sale | 53.6K | $2.32 | $124K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Milestone Pharmaceuticals Inc. (MIST). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| PAPA JOSEPH C | 1 | — |
| Oliveto Joseph | 1 | $82K |
| Wills Robert James | 1 | — |
| Saik Andrew | 1 | — |
| TOMSICEK MICHAEL JOHN | 1 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in MIST insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live MIST dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.